KR20160101706A - 자궁수축억제제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 자궁수축억제제 선택 방법 - Google Patents

자궁수축억제제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 자궁수축억제제 선택 방법 Download PDF

Info

Publication number
KR20160101706A
KR20160101706A KR1020160018785A KR20160018785A KR20160101706A KR 20160101706 A KR20160101706 A KR 20160101706A KR 1020160018785 A KR1020160018785 A KR 1020160018785A KR 20160018785 A KR20160018785 A KR 20160018785A KR 20160101706 A KR20160101706 A KR 20160101706A
Authority
KR
South Korea
Prior art keywords
drug
protein
score
gene
individual
Prior art date
Application number
KR1020160018785A
Other languages
English (en)
Korean (ko)
Inventor
김주한
Original Assignee
싸이퍼롬, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 싸이퍼롬, 인코퍼레이티드 filed Critical 싸이퍼롬, 인코퍼레이티드
Publication of KR20160101706A publication Critical patent/KR20160101706A/ko

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G06F19/22—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • G06F19/18—
    • G06F19/28—
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F19/00—Advertising or display means not otherwise provided for
    • G09F19/12—Advertising or display means not otherwise provided for using special optical effects
    • G09F19/18—Advertising or display means not otherwise provided for using special optical effects involving the use of optical projection means, e.g. projection of images on clouds
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F19/00—Advertising or display means not otherwise provided for
    • G09F19/22—Advertising or display means on roads, walls or similar surfaces, e.g. illuminated

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioethics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Business, Economics & Management (AREA)
  • Accounting & Taxation (AREA)
  • Marketing (AREA)
  • Evolutionary Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Databases & Information Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
KR1020160018785A 2015-02-17 2016-02-17 자궁수축억제제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 자궁수축억제제 선택 방법 KR20160101706A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150024450 2015-02-17
KR20150024450 2015-02-17

Publications (1)

Publication Number Publication Date
KR20160101706A true KR20160101706A (ko) 2016-08-25

Family

ID=56692233

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160018785A KR20160101706A (ko) 2015-02-17 2016-02-17 자궁수축억제제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 자궁수축억제제 선택 방법

Country Status (2)

Country Link
KR (1) KR20160101706A (fr)
WO (1) WO2016133374A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210099858A (ko) * 2020-02-05 2021-08-13 서울대학교산학협력단 폐부종 진단용 바이오마커 및 그의 용도

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107144695B (zh) * 2017-04-19 2019-02-26 南昌大学 Arl13b蛋白在癌症诊断中的应用
CN108566387B (zh) * 2018-03-27 2021-08-20 中国工商银行股份有限公司 基于udp协议进行数据分发的方法、设备以及系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354098T1 (de) * 1998-12-28 2007-03-15 Takeda Pharmaceutical Screening-verfahren
US20030096264A1 (en) * 2001-06-18 2003-05-22 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (MPHTS)
JP2006228079A (ja) * 2005-02-21 2006-08-31 Hitachi Ltd 薬品情報支援システム
EA201691257A1 (ru) * 2011-06-02 2017-02-28 Олмак Дайэгностикс Лимитед Молекулярно-диагностический тест на рак
KR101419753B1 (ko) * 2012-10-16 2014-07-17 안형준 개인 단일 염기 다형성에 기반한 개인별 부작용 최소화 약물 검색 시스템 및 그 방법

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210099858A (ko) * 2020-02-05 2021-08-13 서울대학교산학협력단 폐부종 진단용 바이오마커 및 그의 용도

Also Published As

Publication number Publication date
WO2016133374A1 (fr) 2016-08-25

Similar Documents

Publication Publication Date Title
Lam et al. Comparative genetic architectures of schizophrenia in East Asian and European populations
US20200027557A1 (en) Multimodal modeling systems and methods for predicting and managing dementia risk for individuals
US20210241849A1 (en) Method for personalized selection of a drug for a subject
Cobb et al. Injury research in the genomic era
Dudbridge et al. Predictive accuracy of combined genetic and environmental risk scores
Baye et al. Mapping genes that predict treatment outcome in admixed populations
US20220367063A1 (en) Polygenic risk score for in vitro fertilization
KR20180124840A (ko) 컴퓨터로-구현된 집단에 대한 약물 안전성의 평가
KR20160101706A (ko) 자궁수축억제제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 자궁수축억제제 선택 방법
Dou et al. Using off-target data from whole-exome sequencing to improve genotyping accuracy, association analysis and polygenic risk prediction
KR102482819B1 (ko) 항암제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 항암제 선택 방법
Aegisdottir et al. Genetic variants associated with syncope implicate neural and autonomic processes
KR102482818B1 (ko) 골다공증 치료제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 골다공증 치료제 선택 방법
CN113053460A (zh) 用于基因组和基因分析的系统和方法
Grinde et al. Generalizing genetic risk scores from europeans to Hispanics/Latinos
Manipur et al. CoPheScan: phenome-wide association studies accounting for linkage disequilibrium
Zaghlool et al. Elucidating the genetic risk of obesity through the human blood plasma proteome
KR20220149283A (ko) 전장 유전체 연관 분석 및 가족력 정보를 이용한 알레르기성 질환 예측 방법
Dimartino A machine learning based method to detect genomic imbalances exploiting X chromosome exome reads
WO2024102199A1 (fr) Procédés et systèmes pour le diagnostic et le traitement du lupus fondés sur l'expression des gènes d'immunodéficience primaire
Karczewski et al. Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence
Dewey et al. Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele
Strachan et al. Genome-wide analysis in over 1 million individuals reveals over 2,000 independent genetic signals for blood pressure